IOWA CITY, Iowa (IOWA'S NEWS NOW) — With the U.S. seemingly unable to stop the spread of COVID-19, the pressure is on to find a meaningful way to treat the virus. One new drug, from Regeneron, is so promising it recently received the green light for Phase 3 study. Researchers at the University of Iowa Hospitals and Clinics are among the facilities around the world taking part in this critical phase.

For full article, see https://cbs2iowa.com/news/coronavirus/uihc-taking-part-in-drug-trial-tha...